Loading Page
Dr. Margaret T. Lee, MD is a pediatric oncologist in White Plains, NY specializing in pediatric hematology and general practice. She graduated from University of Santo Tomas Faculty of Medicine and Surgery. Dr. Margaret T. Lee, MD is affiliated with NewYork-Presbyterian, ColumbiaDoctors and ColumbiaDoctors - 15 North Broadway.
Dr. Margaret T. Lee, MD graduated from University of Santo Tomas Faculty of Medicine and Surgery. She completed residency at NYU Langone Medical Center. She is certified by the Board Certification: pediatric hematology-oncology and has a state license in New York.
Medical School: University of Santo Tomas Faculty of Medicine and Surgery
Residency: NYU Langone Medical Center
Board Certification: Board Certification: pediatric hematology-oncology
Licensed In: New York
Dr. Margaret T. Lee, MD is associated with these hospitals and organizations:
Dr. Margaret T. Lee, MD appears to accept the following insurance providers: Emblem/GHI, Emblem/Hip, MVP Health Care, WellCare, Multiplan, AETNA, UnitedHealthcare, Affinity Health Plan, Magnacare (National), Medicare, CIGNA, Local 1199, Fidelis Care, Healthfirst, Empire Blue Cross Blue Shield Healthplus, VNSNY CHOICE, World Trade Center Health Plan, Amida Care, RiverSpring, GHI PPO, CIGNA PPO, CIGNA POS, Aetna Signature Administrators, CIGNA HMO, Blue Shield PPO, CIGNA EPO, Blue Shield HMO, Blue Shield EPO, Medicaid Managed Care, HealthSpring, United Healthcare PPO, United Healthcare POS, United Healthcare HMO, Railroad Medicare, Aetna POS, Vytra, United Healthcare, HIP EPO, Great-West Healthcare, Medicaid, Oxford HMO, Empire BlueCross BlueShield HMO, HIP PPO, HIP POS, HIP HMO, Aetna EPO, Empire BlueCross BlueShield PPO, Aetna PPO, Aetna HMO, Medicare - Traditional Medicare, VNSNY CHOICE - Medicare Managed Care, ElderServe, World Trade Center Health Plan - World Trade Center Health Plan, Healthfirst - Child/Family Health Plus, Healthfirst - Leaf (Exchange), AETNA - Medicare Managed Care, VNSNY CHOICE - Special Needs, MVP Health Care - Essential Plan, AETNA - NY Signature, Empire Blue Cross - EPO, MVP Health Care - HMO, Healthfirst - Medicare Managed Care, AETNA - Student Health, Amida Care - Special Needs, VNSNY CHOICE - SelectHealth, MVP Health Care - Child/Family Health Plus and ElderServe - Special Needs.
According to our sources, Dr. Margaret T. Lee, MD accepts the following insurance providers:
Dr. Margaret T. Lee, MD does not have any reviews yet, be the first to leave a review of Dr. Margaret T. Lee, MD here: Leave a Review
These charts describe general payments received by Dr. Margaret T. Lee, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
|
$125
BRILINTA $125 |
||
|
$122
$122 |
||
|
$105
SOLIRIS $105 |
||
|
$78
Aptima $78 |
||
|
$50
MULTIPLE PRODUCTS $50 |
||
|
$35
LO LOESTRIN FE $23 |
Manta $12 |
| $515 |
Dr. Margaret T. Lee, MD has received 20 research payments totaling $106,726.
Margaret T Lee, MD cares for children with blood disorders, such as anemias (sickle cell anemia, thalassemia, and iron deficiency), bleeding (including idiopathic thrombocytopenic purpura [ITP], hemophilia, and von Willebrand disease), and clotting disorders (such as deep vein thrombosis). Dr. Lee's area of interest is a rare group of diseases called vascular anomalies. There is relatively little known about these disorders, and the care of patients with vascular anomalies requires a multidisciplinary group of physicians from several specialties (dermatology, surgery, cardiology, neurology, and hematology/oncology)-all of whom are available at NewYork-Presbyterian/Morgan Stanley Children's Hospital. Hematologists play a role in the medical treatment of vascular tumors and the supportive care of clotting and bleeding complications that are associated with some types of vascular malformations. Dr. Lee is an active participant in the Vascular Anomalies Group at NYP/Morgan Stanley Children's Hospital, as well as the Vascular Anomalies Special Interest Group of the American Society of Pediatric Hematology/Oncology, which is looking at novel therapies for vascular anomalies and their complications.
